Table 2:
Outcome | Overall cohort (n=88,574) |
Antibiotic exposure days 0–2 (n= 75,353) |
No antibiotic exposure days 0–2 (n= 13,221) |
p-value |
---|---|---|---|---|
Outcomes during days 3–7 | ||||
LOI | 1,437 (1.6%) | 1,154 (1.5%) | 283 (2.1%) | <0.001 |
NEC/SIP | 1,398 (1.6%) | 1,290 (1.7%) | 108 (0.8%) | <0.001 |
Death | 1,726 (1.9%) | 1,566 (2.1%) | 160 (1.2%) | <0.001 |
Composite: LOI + death | 3,055 (3.4%) | 2,633 (3.5%) | 422 (3.2%) | 0.08 |
Age at death for those dying on days 3–7, (median [IQR]) | 5 [3 – 6] | 5 [3 – 6] | 4 [3 – 6] | 0.12 |
Outcomes after day 7 | ||||
LOI after day 7 | 9,834 (11%) | 8,916 (12%) | 918 (7%) | <0.001 |
NEC after day 7 | 5,680 (6%) | 5,099 (7%) | 581 (4%) | <0.001 |
Death after day 7, prior to NICU discharge | 4,840 (6%) | 4,518 (7%) | 322 (3%) | <0.001 |
Age at death (days) for those dying after 7 days, (median [IQR]) | 21 [13 – 39] | 21 [13 – 39] | 21 [12 – 35] | 0.23 |